Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06908122
What this trial is testing

Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences

Who this might be right for
Non-alcoholic Fatty Liver Disease
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT05784779
What this trial is testing

Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD

Who this might be right for
NASHNAFLD
1Globe Biomedical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02421094
What this trial is testing

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Galectin Therapeutics Inc. 30
Large-scale testing (Phase 3)UnknownNCT05731596
What this trial is testing

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Tanta University 46
Early research (Phase 1)Study completedNCT05117489
What this trial is testing

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Corcept Therapeutics 70
Not applicableLooking for participantsNCT05697991
What this trial is testing

Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
King Saud University 1,000
Not applicableStudy completedNCT00930384
What this trial is testing

A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis

Who this might be right for
PsoriasisNonalcoholic Fatty Liver Disease
George Washington University 150
Large-scale testing (Phase 3)Looking for participantsNCT07265297
What this trial is testing

Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis

Who this might be right for
Steatohepatitis, Nonalcoholic
National Taiwan University Hospital 210
Post-approval studies (Phase 4)Study completedNCT00227110
What this trial is testing

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
The University of Texas Health Science Center at San Antonio 55
Large-scale testing (Phase 3)Ended earlyNCT03028740
What this trial is testing

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 1,778
Testing effectiveness (Phase 2)Study completedNCT03061721
What this trial is testing

Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Zydus Therapeutics Inc. 106
Early research (Phase 1)Study completedNCT05983328
What this trial is testing

Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers

Who this might be right for
Nonalcoholic Steatohepatitis
Sinew Pharma Inc. 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Early research (Phase 1)Study completedNCT00706537
What this trial is testing

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

Who this might be right for
Non-Alcoholic Steatohepatitis(NASH)
Pfizer 9
Large-scale testing (Phase 3)Ended earlyNCT00678587
What this trial is testing

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Who this might be right for
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCV+8 more
GlaxoSmithKline 292
Not applicableStudy completedNCT04186793
What this trial is testing

Comparison of Dietary Sugar Reduction Methods

Who this might be right for
Nonalcoholic Fatty Liver Disease
Emory University 8
Early research (Phase 1)Study completedNCT03809052
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Who this might be right for
Safety and Tolerability
Galecto Biotech AB 78
Not applicableStudy completedNCT06499675
What this trial is testing

Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study

Who this might be right for
ObesityObesity, MorbidBariatric Surgery Candidate+2 more
Egyptian Liver Hospital 272
Very early researchStudy completedNCT05523648
What this trial is testing

Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD

Who this might be right for
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
Sichuan Leshan Traditional Chinese Medicine Hospital 92
Not applicableStudy completedNCT03696797
What this trial is testing

Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

Who this might be right for
IronDiabetesNonalcoholic Fatty Liver
Wake Forest University Health Sciences 132
Next Page